13F-HR/A filed by CHI Advisors LLC
CHI Advisors LLC filed this 13F-HR/A for the quarter ended 2023-06-30, filed 2023-08-22, with 26 holding rows worth $329,562,630.
- Accession
- 0001085146-23-003476
- Filer
- CIK 1791468
- Filed
- 2023-08-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, amendment of type restatement, 26 entries on the cover page, a total value of $329,562,630 stated on the cover page (in dollars after the unit check, H1), rows summing to $329,562,630 with VALUE read as dollars as filed, 13F file number 028-19612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,117,017 | $56,480,348 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,663,806 | $55,673,548 | dollars as filed | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 2,782,756 | $46,945,093 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,414,189 | $36,736,673 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,998,734 | $31,726,606 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 402,118 | $16,157,101 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 2,122,040 | $13,920,582 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,829,712 | $8,998,484 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 3,414,468 | $8,720,383 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 852,007 | $8,622,311 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,195,027 | $6,656,301 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 1,055,882 | $5,912,938 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 125,139 | $5,556,172 | dollars as filed | |
| DIREXION SHS ETF TR | 25460G716 | DAILY S&P BIOTEC | 325,000 | $4,670,250 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 755,738 | $3,937,394 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 85,000 | $3,921,050 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 750,000 | $3,787,500 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 542,774 | $3,072,101 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 864,822 | $2,836,616 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 767,445 | $2,417,452 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 1,603,557 | $843,471 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 788,740 | $694,091 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 230,938 | $600,439 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 200,000 | $458,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 130,300 | $161,828 | dollars as filed | call |
| FREELINE THERAPEUTICS HLDGS | 35655L206 | ADR | 21,666 | $55,898 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-003260 | superseded | 2023-08-11 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001085146-23-003476 | this filing | 2023-08-22 | acceptance time not in the bulk data set |